Subunit Stoichiometry of the Epithelial Sodium Channel*

Farhad Kosari, Shaohu Sheng, Jinqing Li, Don-On D. MakDagger , J. Kevin FoskettDagger , and Thomas R. Kleyman§

From the Dagger  Departments of Medicine and Physiology, University of Pennsylvania and Veterans Administration Medical Center, Philadelphia, Pennsylvania 19104

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The epithelial Na+ Channel (ENaC) mediates Na+ reabsorption in a variety of epithelial tissues. ENaC is composed of three homologous subunits, termed alpha , beta , and gamma . All three subunits participate in channel formation as the absence of any one subunit results in a significant reduction or complete abrogation of Na+ current expression in Xenopus oocytes. To determine the subunit stoichiometry, a biophysical assay was employed utilizing mutant subunits that display significant differences in sensitivity to channel blockers from the wild type channel. Our results indicate that ENaC is a tetrameric channel with an alpha 2beta gamma stoichiometry, similar to that reported for other cation selective channels, such as Kv, Kir, as well as voltage-gated Na+ and Ca2+ channels that have 4-fold internal symmetry.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Epithelial Na+ channels are expressed in apical plasma membranes of principal cells in the distal nephron, airway and alveolar epithelia in the lung, surface cells in the distal colon, urinary bladder epithelia, and other tissues including ducts of salivary and sweat glands (1-3). These channels mediate reabsorptive Na+ transport across epithelial cell layers (2-5) and are selectively inhibited by submicromolar concentrations of the diuretic amiloride (6). Epithelial Na+ channels have a key role in the regulation of urinary Na+ reabsorption, extracellular fluid volume homeostasis, and control of blood pressure, and are a major site of action of volume regulatory hormones, including aldosterone (2, 7, 8). The role of Na+ channels in blood pressure regulation has been illustrated in recent studies that have identified mutations in ENaC as the basis of the pathogenesis of Liddle's disease, a disorder characterized by volume expansion and hypertension (9, 10); as well as type I pseudohypoaldosteronism, a disorder characterized by volume depletion and hypotension (11).

The epithelial Na+ channel consists of at least three structurally related subunits, termed alpha -ENaC,1 beta -ENaC, and gamma -ENaC (epithelial Na+ channel) (12). The primary and predicted secondary structures of these ENaCs have been described (12-15). Each subunit has two predicted alpha -helical membrane spanning regions separated by a large extracellular domain. Significant amino acid sequence similarities across species have been observed for individual subunits (on the order of ~60% to greater than 90% amino acid homology), although regions are present that are more highly conserved. A family of genes identified in Caenorhabditis elegans based on mutations that result in mechanosensation defects (mecs) and degeneration of selected neuronal cells (degs) are structurally related to ENaCs (16-18). Several of these genes, including mec-4, mec-6, and mec-10, are thought to form an ion channel in a manner analogous to the three ENaC subunits (16, 19). These observations suggest that ENaCs and mecs (and degs) are members of a new gene superfamily. Members of this family include ENaCs, mecs and degs, FaNaCh (a peptide-gated channel cloned from the marine snail Helix aspers), delta -ENaC, and BNaC (cloned from human brain)), ASIC (an acid-sensing ionic channel), DRASIC (dorsal root ganglia acid-sensing ion channel) (20-24), and likely includes mechanosensitive cation channels present on cochlear hair cells and oocytes (2, 3, 5, 18). Epithelial Na+ channels are composed of at least three structurally distinct subunits (12). We have used a biophysical approach to assess number of each ENaC subunit that assembles to form the Na+ channel complex (i.e. subunit stoichiometry). Our results suggest that ENaC has a tetrameric structure and is composed of two alpha -, one beta -, and one gamma -subunit.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- Reagents were purchased from vendors listed below or from Sigma.

Preparation of Mouse ENaC (mENaC) Mutants-- All three mutants were made using a polymerase chain reaction (PCR)-based mutagenesis technique (25). For each mutant, two rounds of PCR amplification were performed using Pfu DNA polymerase (Stratagene Corp., La Jolla, CA) and an MJ Research thermal cycler (Watertown, MA). Two overlapping fragments were generated in the first round of PCR amplification using the internal mutagenic forward primer with the 3' end external reverse primer and, in a separate reaction, using the internal mutagenic reverse primer with the 5' end external forward primer. In the second round of PCR amplification, the two overlapping fragments generated in the first PCR were first spliced together by two rounds of thermocycling, followed by 22 rounds of amplification with added external primers. The PCR product from the second step was ligated into the original mENaC clone, using unique restriction sites at the two ends. All sequences were confirmed by automated DNA sequence analysis performed at the University of Pennsylvania's DNA sequencing facility.

Expression of Na+ Channels in Xenopus Oocytes-- The mutant and the wild type cRNAs were prepared using a cRNA synthesis kit (m-MESSAGE mMACHINE, Ambion Inc., Austin, TX). cRNA concentration was measured spectroscopically. For optimum ENaC expression, equal amounts (3 ng) of each of the three subunits were injected into oocytes and electrophysiological measurements were performed 1 to 5 days after injection. Two-electrode voltage clamp experiments were performed by clamping oocytes to -100 mV (with reference to bath) for 500 ms and 0 mV for 450 ms. For all measurements, the current difference between the two command potentials was used for data analysis. The difference in current measured in the presence and absence of amiloride (100 µM for wild type mENaC and 1 or 5 mM amiloride for mutant mENaCs) was used to define the amiloride-sensitive current. Amiloride titration measurements were performed under continuous flow (~4 ml/min) of buffers containing varying concentrations of amiloride. Single channel recordings were performed in the cell attached configuration. All data were collected at room temperature and were filtered at 100 Hz. The applied voltage to the membrane patch represents the voltage deflection from the resting membrane potential. Inward Na+ current is represented by a downward deflection in single channel recordings.

Solutions-- Following injection, oocytes were incubated in modified Barth's saline solution containing (in mM): 88 NaCl, 1 KCl, 2.4 NaHCO3, 15 HEPES, 0.3 Ca(NO3)2, 0.41 CaCl2, 0.82 MgSO4, pH 7.2. The buffer was supplemented with 10 µg/ml penicillin, 10 µg/ml streptomycin sulfate, 100 µg/ml gentamycin sulfate, and 10 µg/ml nystatin.

The bath media for two-electrode voltage clamp experiments contained in mM: 100 sodium gluconate, 2 KCl, 1.8 CaCl2 ,10 HEPES, 5 BaCl2, and 10 TEA-Cl, pH 7.2. Measurements of single channel conductance were performed with a buffer containing (in mM): 100 NaCl, 1.8 CaCl2, 2 KCl, 10 HEPES, pH 7.2, in the pipette and in the bath. In patch-clamp studies performed to examine the effects of (2-aminoethyl)methanethiosulfonate (MTSEA, Toronto Research Chemicals Inc., Toronto, Ontario, Canada), the bath solution contained (in mM): 100 potassium gluconate, 2 KCl, 1.8 CaCl2 10 HEPES, 5 BaCl2, 10 TEA-Cl, pH 7.2; the pipette solution in these experiments contained (in mM): 100 LiCl, 1.8 CaCl2, 2 KCl, 10 HEPES, pH 7.2. To investigate the effects of MTSEA on single channels, a 5 mM MTSEA solution was freshly prepared for each patch-clamp, and was perfused into the pipette (26) following single channel recordings in the absence of the drug.

Data Analysis-- Curve fitting and statistical analysis were performed using Matlab software package (The MathWorks, Inc., Natick, MA). The inhibition constant, Ki, and the pseudo Hill coefficient, n', described by the Langmuir inhibition isotherm (Equation 1) were determined by nonlinear regression,
I/I<SUB>o</SUB>=<FR><NU>K<SUP>n′</SUP><SUB>i</SUB></NU><DE>K<SUP>n′</SUP><SUB>i</SUB>+[B]<SUP>n′</SUP></DE></FR>, (Eq. 1)
where I and Io are the macroscopic current in the presence and absence of the blocker (B), respectively.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Wild type and mutant mENaC subunits that express different sensitivities to channel blockers were used to determine mENaC stoichiometry. The injection of oocytes with varying ratios of wild type and mutant mENaC cRNAs results in expression of oligomeric channels, each containing either inhibitor-sensitive and/or inhibitor-insensitive subunits. Analyses of the effects of inhibitors on the expressed channels allows for determination of subunit stoichiometry (27-29). mENaC is blocked by amiloride in the submicromolar range (IC50 of 0.1 µM).2 All three subunits appear to participate in amiloride binding, as single point mutations in the putative pore forming regions of any of these subunits results in altered amiloride binding (30).

The mutants alpha S583C, beta G525C, and gamma G542C were used for these studies, as they differ from wild type ENaC in their sensitivities to channel blockers (30). alpha ,beta G525C,gamma -mENaC and alpha ,beta ,gamma G542C-mENaC are inhibited by amiloride with IC50 values of 73 and 43 µM, respectively (Fig. 1 and Table I). alpha S583C,beta ,gamma -mENaC is blocked by amiloride with an IC50 of 0.6 µM (Table I), sufficiently close to the IC50 of wild type mENaC to preclude the use of amiloride in the determination of the stoichiometry of the alpha -subunit. However, wild type mENaCs are insensitive to the sulfhydryl reagent MTSEA (0.5 mM), whereas alpha S583C,beta ,gamma -ENaC is blocked by MTSEA (Fig. 2A).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   Expression of alpha ,beta G525C,gamma -mENaC or alpha ,beta ,gamma G542C-mENaC in oocytes: amiloride dose-response relationships. Sodium currents were measured in oocytes expressing alpha ,beta G525C,gamma -mENaC (open circles) or alpha ,beta ,gamma G542C-mENaC (closed circles) using a two-electrode voltage clamp (see "Experimental Procedures"). Currents were corrected for the values measured in the presence of 5 mM amiloride and were normalized to the current measured in the absence of amiloride. IC50 values for amiloride and Hill coefficients were determined by curve fitting the amiloride dose-response data to the Langmuir inhibition isotherm (Equation 1). Points represent data obtained from six to 10 experiments. Error bars indicate the standard errors.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Properties of wild type and mutant mENaCs


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   alpha -Subunit stoichiometry. A, responses to MTSEA of oocytes injected with wild type alpha ,beta ,gamma -mENaC or with the mutant alpha S583C,beta ,gamma -mENaC cRNAs. Currents were corrected for the values measured in the presence of 1 mM amiloride and were normalized to the current measured in the absence of amiloride (see "Experimental Procedures"). Wild type alpha ,beta ,gamma -mENaC (open bar) is insensitive to 0.5 mM MTSEA (5 ± 2% inhibition) whereas alpha S583C,beta ,gamma -mENaC mutant (closed bar) is largely blocked (92 ± 2% inhibition) by the drug. Points represent data obtained from six to nine experiments. Error bars indicate the standard errors. B, response to 0.5 mM MTSEA of oocytes co-injected with a 1:1 ratio of wild type alpha ,beta ,gamma -mENaC and mutant alpha S583C,beta ,gamma -mENaC cRNAs (open bar). Currents were corrected for the values measured in the presence of 1 mM amiloride and normalized to currents measured in the absence of amiloride. The right side of the panel illustrates the predicted current response to 0.5 mM MTSEA, assuming an alpha -subunit stoichiometry (n) of one, two, or three. The response to MTSEA (69 ± 2% inhibition) is consistent with a stoichiometry of 2 (predicted response of 71% inhibition). Points represent data obtained from six experiments. Error bar indicates the standard error. C, response to 0.5 mM MTSEA of oocytes co-injected with a 1:4 ratio of wild type alpha ,beta ,gamma -mENaC and mutant alpha S583C,beta ,gamma -mENaC cRNAs (open bar). The right side of the panel illustrates the predicted current response to 0.5 mM MTSEA, assuming an alpha -subunit stoichiometry (n) of one, two, or three. The response to MTSEA (33 ± 6% inhibition) is consistent with a stoichiometry of 2 (predicted response of 37% inhibition). Points represent data obtained from seven experiments. Error bar indicates the standard error.

The analysis of subunit stoichiometry assumes that the functional properties of mutant and wild type channels are similar, other than differential sensitivities to inhibitors. We examined the single channel conductances of the mutant mENaCs (alpha S583C,beta ,gamma -mENaC; alpha ,beta G525C,gamma -mENaC; and alpha ,beta ,gamma G542C-mENaC) expressed in Xenopus oocytes (Fig. 3). The slope conductance of alpha S583C,beta ,gamma -mENaC was 4.7 pS, essentially indistinguishable from wild type mENaC.2 In contrast, the slope conductance for alpha ,beta G525C,gamma -mENaC was 2.8 pS, and for alpha ,beta ,gamma G542C-mENaC was 3.2 pS. These slope conductances are in reasonable agreement with previous observations (30). As the single channel conductances of alpha ,beta G525C,gamma -mENaC and alpha ,beta ,gamma G542C-mENaC differ from wild type alpha ,beta ,gamma -mENaC, these differences were taken into account when determining beta - and gamma -subunit stoichiometry.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Expression of alpha S583C,beta ,gamma -mENaC, alpha ,beta G525C,gamma -mENaC, or alpha ,beta ,gamma G542C-mENaC in oocytes, single channel current/voltage relationships. Currents were measured while varying the holding potential between -100 and +20 (or +100) mV (20 mV steps), using a cell attached patch-clamp. Pipette and oocytes bath solutions contained 100 mM NaCl. Linear current voltage relationships were observed. The slope conductance for alpha S583C,beta ,gamma -mENaC was 4.7 pS, for alpha ,beta G525C,gamma -mENaC was 2.8 pS, and for alpha ,beta ,gamma G542C-mENaC was 3.2 pS. Points represent data obtained from three to 10 experiments. Error bars indicate the standard errors.

alpha -Subunit Stoichiometry-- The differential sensitivities of wild type alpha ,beta ,gamma -mENaC and alpha S583C,beta ,gamma -mENaC to MTSEA were used to determine alpha -subunit stoichiometry. Fig. 2 illustrates the response to MTSEA (0.5 mM) of oocytes injected with a 1:1 (Fig. 2B) or 4:1 (Fig. 2C) mixture of wild type and alpha  mutant (alpha S583C) cRNAs. This figure also illustrates the predicted responses to MTSEA for alpha -subunit stoichiometries (N) of 1, 2, or 3; assuming, 1) a binomial distribution of wild type and mutant alpha -subunits in the expressed mENaCs; and 2) that a single MTSEA-sensitive subunit (i.e. alpha S583C) confers blocker sensitivity to the heteroligomeric channel. The responses of oocytes injected with either 1:1 or 4:1 mixtures of wild type and mutant cRNAs were consistent with an alpha -subunit stoichiometry of two. The maximum likelihood of N to match all data is attained with an n = 2. An n = 2 is e59 times more likely than n = 1, and e23 times more likely than n = 3 to produce the experimental results.

We next examined whether MTSEA-induced block of channels composed of a wild type and a mutant alpha -subunit ENaC (i.e. a hybrid channel) is complete or partial. If MTSEA induces a partial block of the hybrid channel, our results could be consistent with a stoichiometry of greater than 2. Cell-attached patch-clamp was used to examine the effects of MTSEA on single channel currents in oocytes injected with: 1) wild type alpha ,beta ,gamma -mENaC cRNA; 2) alpha S583C,beta ,gamma -mENaC cRNA; 3) or oocytes co-injected with a 1:1 ratio of alpha ,beta ,gamma -mENaC and alpha S583C,beta ,gamma -mENaC cRNAs (Fig. 4). Wild type alpha ,beta ,gamma Na+ channels detected in the absence of MTSEA were also observed following MTSEA infusion into the patch pipette (n = 26) (26). In contrast, all alpha S583C,beta ,gamma Na+ channels detected in the absence of MTSEA were completely blocked following MTSEA infusion (n = 17). Of the 28 Na+ channels observed in oocytes injected with the 1:1 mixture of alpha ,beta ,gamma -mENaC and alpha S583C,beta ,gamma -mENaC cRNAs, no prolonged subconductance state, suggestive of a partial Na+ channel block, was observed following MTSEA infusion. In addition, no flickering response suggestive of a rapid, reversible block of Na+ channels was observed.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Single channel analyses of MTSEA-induced block of mutant (i.e. alpha S583C,beta ,gamma ) mENaCs. Single channel currents were analyzed by cell attached patch-clamp in oocytes injected with: 1) wild type alpha ,beta ,gamma -mENaC cRNA (wt); 2) alpha S583C,beta ,gamma -mENaC cRNA (alpha -mut); 3) or oocytes co-injected with a 1:1 ratio of alpha ,beta ,gamma -mENaC and alpha S583C,beta ,gamma -mENaC cRNAs (wt: alpha -mut = 1:1) (see "Experimental Procedures"). Closed state is indicated as C. A -100 mV potential was applied to the patch. Representative tracings are illustrated prior to MTSEA (A), and following infusion of 5 mM MTSEA into the patch pipette (B). Although brief occasional subconductance states were noted both prior to and following MTSEA infusion, no prolonged subconductance state, suggestive of a partial block of Na+ channels, was observed in oocytes injected with a 1:1 ratio of alpha ,beta ,gamma -mENaC and alpha S583C,beta ,gamma -mENaC cRNAs.

beta -Subunit Stoichiometry-- The differential sensitivities of wild type mENaC and alpha ,beta G525C,gamma -mENaC to amiloride were used to determine beta -subunit stoichiometry. The responses to amiloride of oocytes injected with a 1:1 or a 1:4 mixture of wild type (alpha , beta , gamma ) and mutant (alpha ,beta G525C,gamma ) mENaC cRNAs are illustrated in Fig. 5. This figure also illustrates the predicted responses of oocytes injected with a 1:1 or 1:4 mixture of wild type and mutant cRNAs, for beta -subunit stoichiometries (n) of 1 or 2. A random assembly resulting in a binomial distribution of wild type and mutant beta -subunits expressed in channels was assumed. In generating the predicted responses, the conductance difference between the mutant and the wild type channels has been taken into account (see Fig. 5, legend). If channels are composed of 2 beta -subunit, three distinct populations of channel will be present: (i) wild type channels, (ii) fully mutant channels, and (iii) channels that have both a wild type and a mutant beta -subunit (i.e. hybrid channels). The values for the Ki for amiloride, Hill coefficient, and single channel conductance for the hybrid channels were obtained by minimizing the chi 2 error of the predicted response for a stoichiometry of 2 to the experimental data. Optimized parameters from nonlinear regression were utilized in likelihood ratio analysis. This analysis indicated that n = 1 is e25 times more likely to produce the experimental results than n = 2. Therefore, the experimental data is most consistent with the a beta -subunit stoichiometry of one.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   beta -Subunit stoichiometry. A, unblocked response to amiloride of oocytes co-injected with a 1:1 (open circles) or a 1:4 mixture (closed circles) of wild type (i.e. alpha , beta , gamma ) and mutant (i.e. alpha ,beta G525C,gamma ) mENaC cRNAs. Currents were corrected for the values measured in the presence of 5 mM amiloride and normalized to currents measured in the absence of amiloride. Solid lines illustrate the predicted amiloride dose-response assuming a beta -subunit stoichiometry of one. Dashed lines illustrate the predicted amiloride dose-response assuming a beta -subunit stoichiometry of two. The conductance difference between the wild type and the mutant channels is taken into consideration in calculating the predicted dose-response curve by weighting the probability of occurrence of each species of channel by its conductance. In generating the predicted curve for n = 2, the Ki and Hill coefficient for amiloride and the single channel conductance for hybrid channels (i.e. channels with one wild type and one mutant beta -subunit) were obtained by minimizing the chi 2 error of the predicted response for n = 2 to the experimental results. Points represent data obtained from four to 11 experiments. Error bars indicate the standard errors. B, the amiloride titration data points (A) were transformed according to the following equation,
<FR><NU>1</NU><DE><UP>ln</UP>(f′)</DE></FR> <UP>ln</UP><FENCE><FR><NU>Umix</NU><DE>Ubmut</DE></FR></FENCE>=n−<FR><NU>1</NU><DE><UP>ln</UP>(f′)</DE></FR> <UP>ln</UP><FENCE>1−<FR><NU>R</NU><DE>Umix</DE></FR></FENCE> , (Eq. 2Eq. )
where Umix represents unblocked response from oocytes injected with a 1:4 mixture of wild type (i.e. alpha , beta , gamma ) and mutant (i.e. alpha ,beta G525C,gamma ) mENaC cRNAs. Ubmut denotes unblocked response of alpha ,beta G525C,gamma -mENaC (Fig. 1). R is the unblocked response due to all species containing one or more wild type beta -subunits. f' represents the effective cRNA ratio, that includes a correction for the differences in single channel conductances between wild type and mutant (i.e. alpha ,beta G525C,gamma ) mENaCs, assuming a stoichiometry of 1. Similar data points were observed if f' was optimized for a stoichiometry of 2. As amiloride concentration increases, R diminishes and the right side of Equation 2 approaches n, the stoichiometry. The solid lines represent the theoretical curves for subunit stoichiometry of 1 and 2. Data points are from four to seven experiments. Error bars indicate the standard errors. These data are consistent with a beta -subunit stoichiometry of one.

beta -Subunit stoichiometry can also be illustrated graphically by transforming the amiloride titration data (Fig. 5A) according to Equation 2 (see Fig. 5B, legend). Fig. 5B illustrates the outcome of such a transformation using data collected from oocytes injected with 1:4 ratio of (alpha , beta , gamma ):(alpha ,beta G525C,gamma ) cRNAs. Evident from the figure, as the amiloride concentration increases, the left side of Equation 2 approaches a beta -subunit stoichiometry of one.

gamma -Subunit Stoichiometry-- A similar approach was adopted to determine the stoichiometry of gamma -subunit. The responses to amiloride of oocytes injected with a 1:1 or a 1:4 mixture of wild type (alpha , beta , gamma ) and mutant (alpha ,beta ,gamma G542C) mENaC cRNAs is illustrated in Fig. 6A. The predicted responses for gamma -subunit stoichiometries of 1 and 2 are also plotted in the figure. In generating the predicted response for a stoichiometry of 2, the Hill coefficient, Ki for amiloride and single channel conductance for the hybrid species (channels containing both wild type gamma  and the gamma G542C mutant) were inferred from minimizing chi 2 error by nonlinear regression. Likelihood analysis indicate that n = 1 fits the experimental data e61 times better than n = 2. 


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   gamma -Subunit stoichiometry. A, unblocked response to amiloride of oocytes co-injected with a 1:1 (open circles) or a 1:4 mixture (closed circles) of wild type (i.e. alpha , beta , gamma ) and mutant (i.e. alpha ,beta ,gamma G542C) mENaC cRNAs. Currents were corrected for the values measured in the presence of 5 mM amiloride and were normalized to currents measured in the absence of amiloride. Solid lines illustrate the predicted amiloride dose-response assuming a gamma -subunit stoichiometry of one. Dashed lines illustrate the predicted amiloride dose-response assuming a gamma -subunit stoichiometry of two. The conductance difference between the wild type and the mutant channels is taken into consideration in calculating the predicted dose-response curve by weighting the probability of occurrence of each species of channel by its conductance. In generating the predicted curve for n = 2, the Ki and Hill coefficient for amiloride and the single channel conductance for hybrid channels (i.e. channels with one wild type and one mutant gamma -subunit) were obtained by minimizing the chi 2 error of the predicted response for n = 2 to the experimental results. Points represent data obtained from four to seven experiments. Error bars indicate the standard errors. B, the amiloride titration data points (A) were transformed according to Equation 2 (Fig. 5B), where Umix represents unblocked response from oocytes injected with a 1:4 mixture of wild type (i.e. alpha , beta , gamma ) and mutant (i.e. alpha ,beta ,gamma G542C) mENaC cRNAs. Ugmut, R, and f' are as defined in Fig. 5B (substituting alpha ,beta ,gamma G542C for alpha ,beta G525C,gamma ), where f' is calculated assuming a gamma -subunit stoichiometry of 1. Similar data points were observed if f' was optimized for a stoichiometry of 2. The solid lines represent the theoretical curves for subunit stoichiometry of 1 and 2. Data points are from 5 to 7 experiments. Error bars indicate the standard errors. These data are consistent with a gamma -subunit stoichiometry of one.

Fig. 6B displays the analysis of transformed data obtained from 1:4 mixture of wild type (alpha , beta , gamma ) and mutant (alpha ,beta ,gamma G542C). Similar to the beta -subunit, as amiloride concentration increases, the transformed data approach a value of 1 for gamma -subunit stoichiometry. Therefore, this analysis indicates that a single gamma -subunit takes part in formation of ENaC.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Our analyses of inhibition of wild type and mutant mENaCs suggest that ENaCs are composed of two alpha -subunits, one beta -subunit, and one gamma -subunit. This channel has a quaternary structure, similar to that reported for Kv, Kir, and voltage-gated Na+ and Ca2+ channels (Na+ and Ca2+ channels are composed of a large polypeptide with 4-fold internal symmetry) (27, 29, 31, 32). As mentioned above, the analysis of subunit stoichiometry rests on the assumption that the integration of wild type or mutant subunits into Na+ channels during assembly is a random event. The validity of this assumption is supported by analyses of currents expressed by oocytes injected with mixtures of wild type and mutant subunits that demonstrated that the distribution of these subunits was indeed binomial. Our analysis also rests on the assumption that a single drug-sensitive subunit confers blocker sensitivity to the channel. Again, this is a valid assumption. We demonstrated that channels that have one wild type and one mutant (i.e. alpha S583C) alpha -subunit, or channels that have two mutant alpha -subunits, are completely blocked by MTSEA (Figs. 2, B and C, and 4). As Na+ channels have only one beta -subunit and one gamma -subunit, the presence (or lack) of a mutant beta -subunit (alpha ,beta G525C,gamma ) or mutant gamma -subunit (alpha ,beta ,gamma G542C) determines the sensitivity to amiloride.

Firsov and co-workers (33) have recently reported an ENaC subunit stoichiometry in agreement with what we observed, using both a biophysical approach as well as analysis of ENaC subunit concatemers, although limitations in the use of concatemers to determine stoichiometry of ion channels have been described (34). Snyder and co-workers (35) have recently reported an entirely different ENaC stoichiometry of 3 alpha -, 3 beta -, and 3 gamma -subunits. This proposed stoichiometry of 9 subunits would be unique for an ion channel. In utilizing a biophysical approach to determine subunit stoichiometry, a major assumption is that other than differential sensitivities to inhibitors, functional properties of mutant and wild type channels are similar (27, 28). These authors utilized 2 different mutants to determine gamma -subunit stoichiometry, one of which was used in our study (gamma G542C-mENaC) (35). mENaCs that have this mutant have a single channel conductance that is 69% of wild type. If we did not include a correction for the reduced conductance of the mutant channel, our results would indicate a gamma -subunit stoichiometry of between 1 and 2. The effects of the other subunit mutations (alpha S549C, beta S520C, gamma S529C) on human ENaC functional (single channel) properties were not reported. These mutations are within largely hydrophobic regions preceding the predicted second membrane spanning domain of the channel that appear to participate in the formation of the channel pore. If these mutations introduce changes in human ENaC (hENaC) functional properties in the presence (or absence) of the methanethiosulfonate derivatives used in their study, analyses of the response to inhibitors might lead to an error in determination of subunit stoichiometry. In addition, a determination of stoichiometry requires that the relative amounts of Na+ subunits expressed in oocytes are precisely known. The authors injected hENaC subunit cDNAs into oocytes and examined subsequent functional expression. In this regard, both transcription and translation efficiencies among the different subunits must be similar. The use of cDNAs, rather than cRNAs, introduces an independent variable that is not present in our expression studies.

Snyder and co-workers (35) also examined the mass of hENaC expressed in COS-7 cells and synthesized in vitro in the presence of microsomal membranes by sucrose density sedimentation. A predicted mass of ~950 kDa was observed, and the authors suggest that this size is consistent with an ENaC stoichiometry of 3 alpha -, 3 beta -, and gamma -subunits. However, ENaC is likely associated with cytoskeletal proteins, and these associated proteins may contribute to the apparent size of the ENaC complex, assessed by sucrose density sedimentation. For example, we have observed that ankryin, alpha -spectrin, and the protein Apx (Apical protein Xenopus) (36) co-immunoprecipitate with Xenopus ENaC.3

alpha -Subunits by themselves can form ENaC channels (12, 17). Recent studies, presented in abstract form, suggest that these alpha -subunit channels are composed of four subunits (37), consistent with the tetrameric structure that we report for alpha , beta , gamma  Na+ channels. These studies used an alpha -subunit that has a deletion of a 6-residue tract (rat alpha -ENaCDelta 278-283 (alpha -rENaCDelta 278-283)) that results in a loss of sensitivity of the channel to submicromolar concentrations of amiloride (38). Oocytes expressing alpha Delta 278-283,beta ,gamma -rENaCs have current levels that are markedly lower than currents observed in oocytes expressing wild type alpha ,beta ,gamma -rENaCs (38). This precluded the use of alpha -rENaC Delta 278-283 in our analysis of alpha ,beta ,gamma -ENaC stoichiometry. We previously observed that alpha -subunit channels formed by the mutant alpha -rENaC H282D was insensitive to submicromolar concentrations of amiloride (38). Interestingly, alpha H282D,beta ,gamma -rENaC is inhibited by amiloride with an IC50 similar to wild type alpha ,beta ,gamma -rENaC (data not shown), again precluding the use of this mutant in our analysis of alpha ,beta ,gamma -ENaC stoichiometry. alpha , beta -, Or alpha ,gamma -subunits expressed in oocytes form functional Na+ channels (12). McNicholas and Canessa (39) suggested that alpha ,beta -rENaC and alpha ,gamma -rENaC are composed of equal numbers of alpha - and beta -subunits or of alpha - and gamma -subunits. As our results suggest that ENaCs have a tetrameric structure, we propose that these channels are composed of 2 alpha - and 2 beta -subunits or of 2 alpha - and 2 gamma -subunits.

    ACKNOWLEDGEMENT

We express our sincere thanks to Dr. Martin Pring for assistance with statistical analyses.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants DK51391, DK50268, and HL07027, the Department of Veterans Affairs, and the Cystic Fibrosis Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Medical Research (151), VA Medical Center, University and Woodland Aves., Philadelphia, PA 19104. Tel.: 215-823-5177; Fax: 215-823-5171; E-mail: kleyman{at}mail.med.upenn.edu.

1 The abbreviations used are: ENaC, epithelial Na+ channel; mec, mechanosensation defects; deg, degenerin; PCR, polymerase chain reaction; MTSEA, (2-aminoethyl)methanethiosulfonate.

2 Y. Ahn, F. Kosari, J. Li, and T. R. Kleyman, manuscript in preparation.

3 J. B. Zuckerman, X. Chen, T. R. Kleyman, and P. R. Smith, manuscript in preparation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Duc, C., Farman, N., Canessa, C. M., Bonvalet, J. P., and Rossier, B. C. (1994) J. Cell Biol. 127, 1907-1921[Abstract]
  2. Benos, D. J., Awayda, M. S., Ismailov, I. I., and Johnson, J. P. (1995) J. Membr. Biol. 143, 1-18[Medline] [Order article via Infotrieve]
  3. Rossier, B. C., Canessa, C. M., Schild, L., and Horisberger, J. D. (1994) Curr. Opin. Nephrol. Hypertens. 3, 487-496[Medline] [Order article via Infotrieve]
  4. Smith, P. R., and Benos, D. J. (1991) Annu. Rev. Physiol. 53, 509-530[CrossRef][Medline] [Order article via Infotrieve]
  5. Garty, H. (1994) FASEB J. 8, 522-528[Abstract/Free Full Text]
  6. Kleyman, T. R., and Cragoe, E. J., Jr. (1990) Methods Enzymol. 191, 739-755[Medline] [Order article via Infotrieve]
  7. Verrey, F. (1995) J. Membr. Biol. 144, 93-110[Medline] [Order article via Infotrieve]
  8. Garty, H. (1992) Semin. Nephrol. 12, 24-29[Medline] [Order article via Infotrieve]
  9. Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Jr., Ulick, S., Milora, R. V., Findling, J. W., Canessa, C. M., Rossier, B. C., and Lifton, R. P. (1994) Cell 79, 407-414[Medline] [Order article via Infotrieve]
  10. Hansson, J. H., Nelson-Williams, C., Suzuki, H., Schild, L., Shimkets, R., Lu, Y., Canessa, C., Iwasaki, T., Rossier, B., and Lifton, R. P. (1995) Nat. Genet. 11, 76-82[Medline] [Order article via Infotrieve]
  11. Chang, S. S., Grunder, S., Hanukoglu, A., Rosler, A., Mathew, P. M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R. A., Nelson-Williams, C. N., Rossier, B. C., and Lifton, R. P. (1996) Nat. Genet. 12, 248-253[Medline] [Order article via Infotrieve]
  12. Canessa, C. M., Schild, L., Buell, G., Thorens, B., Gautschl, I., Horisberger, J.-D., and Rossier, B. C. (1994) Nature 367, 463-467[CrossRef][Medline] [Order article via Infotrieve]
  13. Canessa, C. M., Merillat, A. M., and Rossier, B. C. (1994) Am. J. Physiol. 267, C1682-C1690[Abstract/Free Full Text]
  14. Renard, S., Lingueglia, E., Voilley, N., Lazdunski, M., and Barbry, P. (1994) J. Biol. Chem. 269, 12981-12986[Abstract/Free Full Text]
  15. Snyder, P. M., McDonald, F. J., Stokes, J. B., and Welsh, M. J. (1994) J. Biol. Chem. 269, 24379-24383[Abstract/Free Full Text]
  16. Huang, M., and Chalfie, M. (1994) Nature 367, 467-470[CrossRef][Medline] [Order article via Infotrieve]
  17. Canessa, C. M., Horisberger, J.-D., and Rossier, B. C. (1993) Nature 361, 467-470[CrossRef][Medline] [Order article via Infotrieve]
  18. Corey, D. P., and Garcia-Anoveros, J. (1996) Science 273, 323-324[Medline] [Order article via Infotrieve]
  19. Tavernarakis, N., and Driscoll, M. (1997) Annu. Rev. Physiol. 59, 659-689[CrossRef][Medline] [Order article via Infotrieve]
  20. Lingueglia, E., Champigny, G., Lazdunski, M., and Barbry, P. (1995) Nature 378, 730-733[CrossRef][Medline] [Order article via Infotrieve]
  21. Waldmann, R., Champigny, G., Bassilana, F., Voilley, N., and Lazdunski, M. (1995) J. Biol. Chem. 270, 27411-27414[Abstract/Free Full Text]
  22. Garcia-Anoveros, J., Derfler, B., Neville-Golden, J., Hyman, B. T., and Corey, D. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1459-1464[Abstract/Free Full Text]
  23. Waldmann, R., Champigny, G., Bassilana, F., Heurteaux, C., and Lazdunski, M. (1997) Nature 386, 173-177[CrossRef][Medline] [Order article via Infotrieve]
  24. Waldmann, R., Bassilana, F., de Weille, J., Champigny, G., Heurteaux, C., and Lazdunski, M. (1997) J. Biol. Chem. 272, 20975-20978[Abstract/Free Full Text]
  25. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1995) Current Protocols in Molecular Biology, p. 8.5.8, John Wiley and Sons, New York
  26. Tang, J. M., Wang, J., and Eisenberg, R. S. (1992) Methods Enzymol. 207, 176-181[Medline] [Order article via Infotrieve]
  27. MacKinnon, R. (1991) Nature 350, 232-235[CrossRef][Medline] [Order article via Infotrieve]
  28. Ferrer-Montiel, A. V., and Montal, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2741-2744[Abstract/Free Full Text]
  29. Liman, E. R., Tytgat, J., and Hess, P. (1992) Neuron 9, 861-871[Medline] [Order article via Infotrieve]
  30. Schild, L., Schneeberger, E., Gautschi, I., and Firsov, D. (1997) J. Gen. Physiol. 109, 15-26[Abstract/Free Full Text]
  31. Catterall, W. A. (1993) Trends Neurosci. 16, 500-506[CrossRef][Medline] [Order article via Infotrieve]
  32. Yang, J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1441-1447[Medline] [Order article via Infotrieve]
  33. Firsov, D., Gautschi, I., Merillat, A. M., Rossier, B. C., and Schild, L. (1998) EMBO J. 17, 344-352[Abstract/Free Full Text]
  34. McCormack, K., Lin, L., Iverson, L. E., Tanouye, M. A., and Sigworth, F. J. (1992) Biophys. J. 63, 1406-1411[Abstract]
  35. Snyder, P. M., Cheng, C., Prince, L. S., Rogers, J. C., and Welsh, J. M. (1998) J. Biol. Chem. 273, 681-684[Abstract/Free Full Text]
  36. Staub, O., Verrey, F., Kleyman, T. R., Benos, D. J., Rossier, B. C., and Kraehenbuhl, J. P. (1992) J. Cell Biol. 119, 1497-1506[Abstract]
  37. Berdiev, B. K., Karlson, K. H., Kozak, F., Stanton, B. A., Kleyman, T. R., and Ismailov, I. I. (1998) Biophys. J. 74, A402 (abstr.)
  38. Ismailov, I. I., Kieber-Emmons, T., Lin, C., Berdiev, B. K., Shlyonsky, V. G., Patton, H. K., Fuller, C. M., Worrell, R., Zuckerman, J. B., Sun, W., Eaton, D. C., Benos, D. J., and Kleyman, T. R. (1997) J. Biol. Chem. 272, 21075-21083[Abstract/Free Full Text]
  39. McNicholas, C. M., and Canessa, C. (1997) J. Gen. Physiol. 109, 681-692[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.